David C. Sachs serves as Executive at ImmunityBio, Inc., where they oversee executive responsibilities. Since joining the company, David C. Sachs has executed 14 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 22, 2026 involved exercising options for 40,650 shares valued at $0.
David C. Sachs currently holds 40,651 shares of ImmunityBio, Inc. (IBRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David C. Sachs has been a net neutral trader of IBRX stock. They have purchased $0 and sold $0 worth of shares.
David C. Sachs's most recent insider trade was on Feb 22, 2026, when they sold 40,650 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.70 |
| Discretionary |
| Feb 22, 2026 | IBRX | $0 | Option Exercise | 40,650 | $N/A | Discretionary |
| Dec 31, 2025 | IBRX | $0 | Option Exercise | 30,397 | $N/A | Discretionary |
| Dec 31, 2025 | IBRX | $30.6K | Payment | 15,435 | $1.98 | Discretionary |
| Dec 31, 2025 | IBRX | $0 | Option Exercise | 30,397 | $N/A | Discretionary |
| Jan 31, 2024 | IBRX | $0 | Option Exercise | 70,745 | $N/A | Discretionary |
| Jan 31, 2024 | IBRX | $90.2K | Payment | 26,835 | $3.36 | Discretionary |
| Dec 31, 2023 | IBRX | $0 | Option Exercise | 30,397 | $N/A | Discretionary |
| Dec 31, 2023 | IBRX | $52.8K | Payment | 10,511 | $5.02 | Discretionary |
| Sep 1, 2023 | IBRX | $0 | Option Exercise | 70,744 | $N/A | Discretionary |
| Dec 31, 2022 | IBRX | $0 | Option Exercise | 7,598 | $N/A | Discretionary |
| Dec 9, 2021 | IBRX | $0 | Option Exercise | 17,242 | $N/A | Discretionary |
| Sep 9, 2021 | IBRX | $0 | Option Exercise | 7,598 | $N/A | Discretionary |